Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand

finance.yahoo.com/news/novo-nordisk-cuts-2025-outlook-114248185.html

In This Article:
Novo Nordisk has reduced its sales and profits forecasts for 2025 due to lower-than-expected demand in the US for blockbuster weight loss and diabetes drugs, though shares in the company were still up following positive Q1 results.
Despite feeling the effects from the…

This story appeared on finance.yahoo.com, 2025-05-07 11:42:48.
The Entire Business World on a Single Page. Free to Use →